Introduction Valproic acid (VPA) is a broad-spectrum antiepileptic drug (AED) that has been used for more than 30 years and is effective in the treatment of many different types of partial and generalized epileptic seizure
However, its important to assess how much of this perceived benefit is supported by evidence and what outcomes practitioners and patients can realistically expect
In addition, the use of TNF- inhibitors is accompanied by certain risks
Statistical Analyses A repeated measures general linear model was used to examine for differences in outcome measures between groups (1.5 g/d, 1 g/d, 4.5 g/d), conditions (pre- and post-GPLC) and across time
What matters most to you right now?
Understanding why the evidence for DSIP is weak, and being able to say so plainly, is itself a clinical skill